Last reviewed · How we verify
NCT04407780: CONFUCIUS
Cardio-Oncology Registry
trial testing No interventions are planned in Cancer in 5,000 participants. Currently enrolling.
1 June 2022
Quick facts
| Lead sponsor | European Georges Pompidou Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 5,000 |
| Start date | 1 January 2017 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 June 2027 |
| Sites | 1 location across France |
Drugs / interventions tested
- No interventions are planned
Conditions studied
- Cancer — all drugs for Cancer →
- Cardiac Disease — all drugs for Cardiac Disease →
- Metabolic Syndrome — all drugs for Metabolic Syndrome →
- Arrhythmia — all drugs for Arrhythmia →
Sponsor
European Georges Pompidou Hospital
Who can join
18 and older, any sex, with Cancer or Cardiac Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cardio-oncology is an emerging field. Most of the data available have been issued from either retrospective analysis, industry data or pharmacovigilance data. These data sources include a number of bias. CONFUCIUS is a single tertiary centre prospective registry including all patients who have been referred for cardio-oncology assessemnt. The objectives are to provide a comprehensive vue of cardoi-oncology, enable to detect early signals of cardiotoxicity and enhance ancillary projetcts aiming at specific populations (e.g., type of cancer) and/or drugs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04407780
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No interventions are planned
Trials testing the same drug.
- NCT05794256 — Genderspecific Differences in Hormone Levels After Trauma · unknown
- NCT03892798 — Database Of Clinical Data For Individuals With Variants In The IRF2BPL Gene · completed
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other European Georges Pompidou Hospital trials
Trials by the same sponsor.
- NCT07059715 — Mic Mac: Micro- and Macrocirculatory Assessment During Cardiac Surgery in Patients at Risk of Vasoplegic Syndrome: A Pro · recruiting
- NCT04407858 — Cardiovascular Complications of Carfilzomib · unknown
- NCT04407845 — Atrial Fibrillation in Patients Receiving Ibrutinib · unknown
- NCT07093320 — Saving Limbs After Cancer: Blood Vessel and Soft Tissue Reconstruction Following Sarcoma Surgery in the Legs · completed
- NCT04591509 — Predictability of Echographic Excursion of the Diaphragm for Intubation in COPD- Patients With Acute Respiratory Failure · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04407780 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by European Georges Pompidou Hospital
- Last refreshed: 29 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04407780.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing